India stocks, rupee, swaps, call at close
MUMBAI, Oct 30 (Reuters) -
STOCKS:
The BSE Sensex .BSESN was down 0.53% at 79,942 points, while the NSE Nifty 50 index .NSEI declined by 0.51% to 24,342 dragged down by high-weightage financials and as drugmaker Cipla extended its post-results losses. .BO
RUPEE:
The Indian rupee INR=IN was largely unchanged at 84.0775 per U.S. dollar, swaying between month-end dollar demand from importers and central bank intervention. INR/
GOVERNMENT BONDS:
The benchmark 10-year bond IN071034G=CC was quoted at 101.87 rupees, with the yield down 3 bps at 6.8271%, as value purchases continued, while falling U.S. Treasury yields and oil prices further aided sentiment. IN/
OVERNIGHT INDEX SWAPS:
The one-year overnight index swap rate INR1YMIBROIS=CC was down 2 basis points at 6.52%, while the five-year swap rate INR5YMIBROIS=CC declined by a similar margin to 6.22%.
CALL MONEY:
India's overnight call money INROND= rate was at 5.80%, and the overnight TREPS rate INTREPTOT=TCCL was at 6.30%.
Reporting by Dharamraj Dhutia; Editing by Mrigank Dhaniwala
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
